UBS Group
CVM icon

UBS Group’s CEL-SCI Corp CVM Stock Holding History

UBS Group’s Portfolio CVM Stock Details CVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-52,880
Closed -$13.8M – 9618
2021
Q2 		$13.8M Buy
52,880
+25,860
+96% +$16M ﹤0.01% 1780
2021
Q1 		$12.3M Buy
27,020
+26,357
+3,975% +$14.4M ﹤0.01% 1778
2020
Q4 		$232K Buy
+663
New +$262K ﹤0.01% 5153
2020
Q3 		– Sell
-1,667
Closed -$746K – 8047
2020
Q2 		$746K Buy
+1,667
New +$684K ﹤0.01% 3776

Other funds holding CVM

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $26.6B AUM 22.97% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group's CVM Position: Q2 2026 in Review

UBS Group reduced its CEL-SCI Corp (CVM) stake by 52% in Q2 2026, selling an estimated $18.9K and leaving 8,025 shares worth $8.35K. The position accounts for ﹤0.01% of the portfolio, ranked #8688.

UBS Group first reported a position in CVM in Q4 2014 and has held it in 47 quarters since. The position peaked at $2.55M in Q3 2021. 40 funds tracked by Wall St. Rank hold CVM as of Q2 2026.

  • UBS Group held 8,025 shares of CEL-SCI Corp worth $8.35K as of Q2 2026.
  • UBS Group sold 8,612 CEL-SCI Corp shares in Q2 2026, an estimated $18.9K.
  • CEL-SCI Corp made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #8688 holding.
  • UBS Group first reported a position in CEL-SCI Corp in Q4 2014 and has held it in 47 quarters since.
  • UBS Group's CEL-SCI Corp position peaked at $2.55M in Q3 2021.
  • 40 funds tracked by Wall St. Rank held CEL-SCI Corp as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.